8-K
filed February 27, 2024, 6:59 PM ET
ticker XRN
CIK 0001533615
earnings
confidence high
sentiment negative
materiality 0.70
Global Medical REIT posts Q4 net loss of $0.8M; full-year AFFO $0.91/share, leverage down to 43.6%
Chiron Real Estate Inc.
2023-FY EPS reported
$0.23
revenue$141,049,000
- Q4 net loss attributable to common stockholders of $0.8M ($0.01 diluted loss per share), vs net income $0.4M in Q4 2022.
- Q4 FFO $13.3M ($0.19/share), down from $15.5M ($0.22/share) YoY; AFFO $15.9M ($0.23/share) vs $16.5M ($0.24/share) YoY.
- Total revenue $33.0M, down 9.2% YoY, due to dispositions and $1.1M rent reserve recognized.
- Full-year 2023 dispositions generated $80.5M gross proceeds; leverage reduced to 43.6% from 47.6% at year-end 2022.
- Portfolio 96.5% occupied; acquisition pipeline $95M-$110M for 2024; no ATM issuance in 2023 or YTD 2024.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Chiron Real Estate Inc. reported year ended December 31, 2023 results: net income 14.8 million, EPS 0.23.
- Period
- year ended December 31, 2023
- Net income
- 14.8 million
- EPS
- 0.23
- Result
- reported results
Exact text from the filing
Net income attributable to common stockholders was $14.8 million, or $0.23 per diluted share
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Chiron Real Estate Inc. reported three months ended December 31, 2023 results: revenue 33.0 million, net income -0.8 million, EPS -0.01.
- Period
- three months ended December 31, 2023
- Revenue
- 33.0 million
- Net income
- -0.8 million
- EPS
- -0.01
- Result
- reported results
Exact text from the filing
Total revenue decreased 9.2% year-over-year to $33.0 million
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Chiron Real Estate Inc. reported three months ended December 31, 2023 results: revenue 33.0 million, net income -0.8 million, EPS -0.01.
- Period
- three months ended December 31, 2023
- Revenue
- 33.0 million
- Net income
- -0.8 million
- EPS
- -0.01
- Result
- reported results
Exact text from the filing
or $0.23 per share and unit, as compared to $16.5 million, or $0.24 per share and unit, in the comparable prior year period. · Total revenue decreased 9.2% year-over-year to $33.0 million, primarily driven by the Company’s property dispositions completed during the first nine months of 2023, as well as the recognition of reserves for approximately $1.1 million of
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.